We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy with this. For more information about how we use cookies and how to change your settings click here.
 

Follow us on Twitter Follow us on LinkedIn

020 7759 2285

Fund Investments

  • Parkwalk closes DefiniGen investment for theUniversity of Cambridge Enterprise Fund I
    DefiniGEN
    DefiniGEN provides human cells to the drug discovery sector for use in lead optimization and toxicity programmes.

    The Company’s proprietary production platform OptiDIFF robustly generates human cell types including liver hepatocytes using hIPSC human Induced Pluripotent Stem Cell technology.
  • Parkwalk closes Clean Air Power investment for the UK Tech Fund III
    Clean Air Power
    Clean Air Power has pioneered the move towards using natural gas to power vehicles by developing Dual-Fuel™ technologies that guarantee diesel engine performance, with significant cost savings and low carbon emissions.

    Minimal changes are required to the existing diesel engine and by burning up to 90% natural gas, customers benefit from a combination of low emissions and high efficiency.
  • Parkwalk closes Cambridge CMOSS investment for the University of Cambridge Enterprise Fund I and the UK Tech Fund III
    Cambridge CMOSS
    Cambridge CMOS Sensors is the provider of innovative MEMS high temperature microhotplate technology for gas sensing, flow sensing and lab-on-a-chip applications.

    The Cambridge CMOS Sensors technology uses standard CMOS processes that enable high volume, low cost and low power sensor-on-chip solutions.
  • Parkwalk closes Arkivum investment for the UK Tech Fund III
    Arkivum
    Arkivum has developed a safe and simple process to manage data security and safety. The company has developed 'best practice' for the long term preservation of digital data.

    The process has the highest integrity to ensure information remains in bit-perfect condition all the time.
  • Parkwalk closes Arvia investment for the UK Tech Fund II
    Arvia Technology
    Arvia represents a dramatic change from the traditional methods for treating organic liquid waste.

    This 'game changing' technology removes and destroys organic contaminants and oils using a method that is free of process chemicals, is energy efficient, and produces little solid or liquid waste for disposal.
  • Parkwalk closes Surrey Nano Sytems investment for the UK Tech Fund II
    Surrey Nano Systems
    Surrey NanoSystems has developed a leading technology portfolio addressing the needs of the global nanoelectronics sector.

    Its proven technologies deliver precise, ordered nanomaterial structures for advanced CMOS manufacturing processes.

Subscribe to Newsletters

Newsletter request submitted!
We will be in touch soon.

Portfolio News

2009 '10 '11 '12 '13